Jay Thiagarajah
Boston Children's Hospital
Appearances
- DateMay 8, 2023Reactive oxygen species (ROS) are by-products of normal cellular metabolism with low to moderate amounts being beneficial in several physiological processes in the intestine. Chemotherapy and radiotherapies are largely based upon ROS generation to destroy malignant cells by inducing apoptosis…
Moderators
Boston Children's HospitalUniv of Illinois at Chicago - DateMay 7, 2023BACKGROUND: RNA-binding motif protein 47 (RBM47) is a component of the APOBEC-1 dependent C-to-U RNA editosome required for RNA editing. However, the range of targets and functions of RBM47 in intestine is unknown…
Speakers
Vanderbilt University Medical CenterPresenter
Boston Children's Hospital - DateMay 19, 2024BACKGROUND: Multiple studies have identified interleukin (IL)-1 proteins (IL-1α, IL-1β) as playing a key role in intestinal inflammation, including the expansion of IL-1 expressing cells as a hallmark of severe and anti-TNFα non-responsive inflammatory bowel disease (IBD)…
Presenter
Speakers
Boston Children's HospitalBoston Children's HospitalBrigham and Women's Hospital - DateMay 4, 2025This session aims to provide a comprehensive overview of the transformative insights gained through super-resolution microscopy, emphasizing its impact on our understanding of intestinal biology and its potential to drive innovative approaches in gastrointestinal research and medicine…
Moderators
Department of Pathology & Laboratory Medicine Rutgers New Jersey School of MedicineBoston Children's Hospital